952195-24-3

Upstream product

• 16588-34-4 4-chloro-3-nitro-benzaldehyde 
• 55912-20-4 4-chloro-3-nitrobenzyl alcohol 
• 952194-80-8 N-(5-acetyl-2-chloro-phenyl)-3,4-dimethoxy-benzenesulfonamide 
• 952194-79-5 N-[2-chloro-5-(1-hydroxy-ethyl)-phenyl]-3,4-dimethoxy-benzenesulfonamide 
• 952194-77-3 N-(2-chloro-5-hydroxymethyl-phenyl)-3,4-dimethoxy-benzenesulfonamide 
• 952194-78-4 N-(2-chloro-5-formyl-phenyl)-3,4-dimethoxy-benzenesulfonamide 
• 952194-81-9 N-[2-chloro-5-(1-hydroxy-1-methyl-ethyl)-phenyl]-3,4-dimethoxy-benzenesulfonamide 
• 2315-36-8 2-Chloro-N,N-diethylacetamide 

Relevant academic research and scientific papers

NOVEL SULFONAMIDE COMPOUNDS

The invention relates to novel sulfonamide compounds and their use as orexin receptor antagonists.

NOVEL SULFONAMIDE COMPOUNDS

The invention relates to sulfonamide compounds of formula (I), where A, B, R3 and R4 are as defined in the claims, and their use as orexin receptor antagonists in the prevention and treatment of eating and drinking disorders, all types of sleep disorders, all kinds of cognitive dysfunctions in the healthy population and psychiatric and neurologic disorders. Formula (I).